Your browser doesn't support javascript.
loading
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) Study.
Kim, Helena K; Zai, Gwyneth; Müller, Daniel J; Husain, Muhammad I; Lam, Raymond W; Frey, Benicio N; Soares, Claudio N; Parikh, Sagar V; Milev, Roumen; Foster, Jane A; Turecki, Gustavo; Farzan, Faranak; Mulsant, Benoit H; Kennedy, Sidney H; Tripathy, Shreejoy J; Kloiber, Stefan.
Affiliation
  • Kim HK; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Zai G; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Müller DJ; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
  • Husain MI; Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Lam RW; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Frey BN; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
  • Soares CN; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Parikh SV; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
  • Milev R; Department of Psychiatry, University of British Columbia, Vancouver, Canada.
  • Foster JA; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Canada.
  • Turecki G; Mood Disorders Program and Women's Health Concerns Clinic, St. Joseph's Healthcare, Hamilton, Canada.
  • Farzan F; Department of Psychiatry, Queen's university School of Medicine, Kingston, Canada.
  • Mulsant BH; Department of Psychiatry, University of Michigan, Ann Arbor, United States of America.
  • Kennedy SH; Department of Psychiatry, Queen's university School of Medicine, Kingston, Canada.
  • Tripathy SJ; Department of Psychiatry, Providence care, Kingston, Canada.
  • Kloiber S; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Canada.
Pharmacopsychiatry ; 55(6): 297-303, 2022 Nov.
Article in En | MEDLINE | ID: mdl-35793696
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depressive Disorder, Major Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Pharmacopsychiatry Year: 2022 Document type: Article Affiliation country: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depressive Disorder, Major Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Pharmacopsychiatry Year: 2022 Document type: Article Affiliation country: Canada